Scientists argue that cane sugar and beef tallow offer no measurable health benefits over corn syrup and vegetable oil, but ...

The H5N1 bird flu virus has historically extracted a heavy toll when it infects humans, with nearly half of confirmed cases ...

HHS Secretary Robert F. Kennedy Jr. formally accepted recommendations that would require all vaccine manufacturers to ...

A new biotech called Dispatch Bio launched today with the goal of developing a new, universal approach to try to treat any cancer using immunotherapy.

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it deli ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  The House of ...

Sarepta faces an “arduous and treacherous path” to try to get its Duchenne muscular dystrophy therapy Elevidys back onto the ...

Dispatch Bio is developing a universal immunotherapy by trying to install a synthetic protein — called the “flare” antigen — on every cancer cell in a patient's body.

Roche is following its partner Sarepta and halting shipments of the Duchenne gene therapy Elevidys in some countries, amid ...

Improvements in rural cancer care in Kentucky could be imperiled by President Trump's tax and domestic policy bill.

A digital intervention using the Apple Watch helped people on Medicaid better control their asthma, illustrating the ...

What if the Trump cost cuts could be used to streamline bureaucracy to actually improve children's access to health care?